Similarly, Pozniak and colleagues showed that overexpression of TCF4 leads to decreases in TNF-α and T cell activation and suppression of TCF4 elicits inflammation, including increases in IFNs, thereby increasing the sensitivity of immune checkpoint inhibitors used to treat melanoma (51). Here, TNF is linked to melanoma.